{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T07:18:21Z","timestamp":1781421501172,"version":"3.54.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T00:00:00Z","timestamp":1106956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1007\/s00213-005-2146-1","type":"journal-article","created":{"date-parts":[[2005,1,28]],"date-time":"2005-01-28T13:35:23Z","timestamp":1106919323000},"page":"159-168","source":"Crossref","is-referenced-by-count":54,"title":["Lamotrigine has an anxiolytic-like profile in the rat conditioned emotional response test of anxiety: a potential role for sodium channels?"],"prefix":"10.1007","volume":"180","author":[{"given":"N. R.","family":"Mirza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. L.","family":"Bright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. J.","family":"Stanhope","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. R.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,1,29]]},"reference":[{"key":"2146_CR1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0028-3908(99)00058-1","volume":"38","author":"AF Ambrosio","year":"1999","unstructured":"Ambrosio AF, Silva AP, Malva JO, Soares-da-Silva P, Carvalho AP, Carvalho CM (1999) Carbamazepine inhibits L-type Ca2+ channels in cultured rat hippocampal neurons stimulated with glutamate receptor agonists. Neuropharmacology 38:1349\u20131359","journal-title":"Neuropharmacology"},{"key":"2146_CR2","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00213-003-1558-z","volume":"170","author":"LJ Bertoglio","year":"2003","unstructured":"Bertoglio LJ, Carobrez AP (2003) Anxiolytic-like effects of NMDA\/glycine-B receptor ligands are abolished during the elevated plus-maze trial 2 in rats. Psychopharmacology (Berl) 170:335\u2013342","journal-title":"Psychopharmacology (Berl)"},{"key":"2146_CR3","first-page":"evidence","volume":"pain","author":"Blackburn-Munro","year":"2004","unstructured":"Blackburn-Munro G, Ericksen HK (2004) Antiepileptics in the treatment of neuropathic pain: evidence from animal models. Pharm Des (in press)","journal-title":"Antiepileptics in the treatment of neuropathic"},{"key":"2146_CR4","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF02245123","volume":"108","author":"DC Blanchard","year":"1992","unstructured":"Blanchard DC, Blanchard RJ, Carobrez AP, Veniegas R, Rodgers RJ, Shepherd JK (1992) MK-801 produces a reduction in anxiety-related antipredator defensiveness in male and female rats and a gender-dependent increase in locomotor behavior. Psychopharmacology (Berl) 108:352\u2013362","journal-title":"Psychopharmacology (Berl)"},{"key":"2146_CR5","volume-title":"Merck index","author":"S Budavari","year":"1989","unstructured":"Budavari S, O\u2019Neill MJ, Smith A, Heckelman PE (1989) Merck index. Merck & Co., Rahway, NJ"},{"key":"2146_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0304-3959(96)03168-5","volume":"68","author":"S Canavero","year":"1996","unstructured":"Canavero S, Bonicalzi V (1996) Lamotrigine control of central pain. Pain 68:179\u2013181","journal-title":"Pain"},{"key":"2146_CR7","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0920-1211(92)90065-2","volume":"13","author":"H Cheung","year":"1992","unstructured":"Cheung H, Kamp D, Harris E (1992) An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res 13:107\u2013112","journal-title":"Epilepsy Res"},{"key":"2146_CR8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/00008877-199711000-00019","volume":"8","author":"C Cohen","year":"1997","unstructured":"Cohen C, Perrault G, Sanger DJ (1997) Assessment of the antidepressant-like effects of L-type voltage-dependent channel modulators. Behav Pharmacol 8:629\u2013638","journal-title":"Behav Pharmacol"},{"key":"2146_CR9","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/BF02246029","volume":"104","author":"R Corbett","year":"1991","unstructured":"Corbett R, Fielding S, Cornfeldt M, Dunn RW (1991) GABAmimetic agents display anxiolytic-like effects in the social interaction and elevated plus maze procedures. Psychopharmacology (Berl) 104:312\u2013316","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 1","key":"2146_CR10","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1177\/0883073897012001031","volume":"12","author":"DA Coulter","year":"1997","unstructured":"Coulter DA (1997) Antiepileptic drug cellular mechanisms of action: where does lamotrigine fit in? J Child Neurol 12(Suppl 1):S2\u2013S9","journal-title":"J Child Neurol"},{"key":"2146_CR11","doi-asserted-by":"crossref","first-page":"S233","DOI":"10.1212\/WNL.47.6_Suppl_4.233S","volume":"47","author":"A Doble","year":"1996","unstructured":"Doble A (1996) The pharmacology and mechanism of action of riluzole. Neurology 47:S233\u2013S241","journal-title":"Neurology"},{"key":"2146_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-2999(93)90147-A","volume":"235","author":"MW Debono","year":"1993","unstructured":"Debono MW, Le GJ, Canton T, Doble A, Pradier L (1993) Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes. Eur J Pharmacol 235:283\u2013289","journal-title":"Eur J Pharmacol"},{"key":"2146_CR13","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0028-3908(97)00042-7","volume":"36","author":"MS Duxon","year":"1997","unstructured":"Duxon MS, Kennett GA, Lightowler S, Blackburn TP, Fone KC (1997) Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. Neuropharmacology 36:601\u2013608","journal-title":"Neuropharmacology"},{"key":"2146_CR14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0091-3057(98)00014-8","volume":"60","author":"S Ganouni El","year":"1998","unstructured":"El Ganouni S, Tazi A, Hakkou F (1998) Potential serotonergic interactions with the anxiolytic-like effects of calcium channel antagonists. Pharmacol Biochem Behav 60:365\u2013369","journal-title":"Pharmacol Biochem Behav"},{"key":"2146_CR15","first-page":"284","volume":"136","author":"I Geller","year":"1962","unstructured":"Geller I, Seifter J (1962) The effects of mono-urethans, di-urethans and barbiturates on a punishment discrimination. J Pharmacol Exp Ther 136:284\u2013288","journal-title":"J Pharmacol Exp Ther"},{"key":"2146_CR16","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0006-3223(99)00011-6","volume":"45","author":"MA Hertzberg","year":"1999","unstructured":"Hertzberg MA, Butterfield MI, Feldman ME, Beckham JC, Sutherland SM, Connor KM, Davidson JR (1999) A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 45:1226\u20131229","journal-title":"Biol Psychiatry"},{"key":"2146_CR17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1528-1157.1997.tb01729.x","volume":"38","author":"DA Hosford","year":"1997","unstructured":"Hosford DA, Wang Y (1997) Utility of the lethargic (lh\/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia 38:408\u2013414","journal-title":"Epilepsia"},{"key":"2146_CR18","first-page":"1280","volume":"282","author":"CS Huang","year":"1997","unstructured":"Huang CS, Song JH, Nagata K, Yeh JZ, Narahashi T (1997) Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J Pharmacol Exp Ther 282:1280\u20131290","journal-title":"J Pharmacol Exp Ther"},{"key":"2146_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1538\/expanim.51.19","volume":"51","author":"H Ito","year":"2002","unstructured":"Ito H, Nishibayashi M, Kawabata K, Maeda S, Seki M, Ebukuro S (2002) Immunohistochemical demonstration of c-fos protein in neurons of the medulla oblongata of the musk shrew (Suncus murinus) after veratrine administration. Exp Anim 51:19\u201325","journal-title":"Exp Anim"},{"key":"2146_CR20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0091-3057(97)00413-9","volume":"59","author":"HE Jones","year":"1998","unstructured":"Jones HE, Balster RL (1998) Muscimol-like discriminative stimulus effects of GABA agonists in rats. Pharmacol Biochem Behav 59:319\u2013326","journal-title":"Pharmacol Biochem Behav"},{"key":"2146_CR21","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0028-3908(97)00130-5","volume":"36","author":"M Karcz-Kubicha","year":"1997","unstructured":"Karcz-Kubicha M, Jessa M, Nazar M, Plaznik A, Hartmann S, Parsons CG, Danysz W (1997) Anxiolytic activity of glycine-B antagonists and partial agonists\u2014no relation to intrinsic activity in the patch clamp. Neuropharmacology 36:1355\u20131367","journal-title":"Neuropharmacology"},{"key":"2146_CR22","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1111\/j.1476-5381.1996.tb15304.x","volume":"117","author":"GA Kennett","year":"1996","unstructured":"Kennett GA, Bright F, Trail B, Baxter GS, Blackburn TP (1996) Effects of the 5-HT2B receptor agonist, BW 723C86, on three rat models of anxiety. Br J Pharmacol 117:1443\u20131448","journal-title":"Br J Pharmacol"},{"key":"2146_CR23","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0091-3057(91)90187-7","volume":"39","author":"R Kirac","year":"1991","unstructured":"Kirac R, Eroglu L (1991) Bay K 8644 potentiates the anxiolytic effect of ethanol. Pharmacol Biochem Behav 39:325\u2013327","journal-title":"Pharmacol Biochem Behav"},{"key":"2146_CR24","first-page":"712","volume":"54","author":"CC Kuo","year":"1998","unstructured":"Kuo CC (1998) A common anticonvulsant binding site for phenytoin, carbamazepine, and lamotrigine in neuronal Na+ channels. Mol Pharmacol 54:712\u2013721","journal-title":"Mol Pharmacol"},{"key":"2146_CR25","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1124\/mol.51.6.1077","volume":"51","author":"CC Kuo","year":"1997","unstructured":"Kuo CC, Chen RS, Lu L, Chen RC (1997) Carbamazepine inhibition of neuronal Na+ currents: quantitative distinction from phenytoin and possible therapeutic implications. Mol Pharmacol 51:1077\u20131083","journal-title":"Mol Pharmacol"},{"key":"2146_CR26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1528-1157.1986.tb03573.x","volume":"27","author":"MJ Leach","year":"1986","unstructured":"Leach MJ, Marden CM, Miller AA (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action. Epilepsia 27:490\u2013497","journal-title":"Epilepsia"},{"issue":"Suppl 2","key":"2146_CR27","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1111\/j.1528-1157.1991.tb05882.x","volume":"32","author":"MJ Leach","year":"1991","unstructured":"Leach MJ, Baxter MG, Critchley MA (1991) Neurochemical and behavioral aspects of lamotrigine. Epilepsia 32(Suppl 2):S4\u2013S8","journal-title":"Epilepsia"},{"key":"2146_CR28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0091-3057(94)90422-7","volume":"49","author":"S Lightowler","year":"1994","unstructured":"Lightowler S, Kennett GA, Williamson IJ, Blackburn TP, Tulloch IF (1994) Anxiolytic-like effect of paroxetine in a rat social interaction test. Pharmacol Biochem Behav 49:281\u2013285","journal-title":"Pharmacol Biochem Behav"},{"key":"2146_CR29","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0014-2999(94)90645-9","volume":"264","author":"Y Matsumoto","year":"1994","unstructured":"Matsumoto Y, Kataoka Y, Watanabe Y, Miyazaki A, Taniyama K (1994) Antianxiety actions of Ca2+ channel antagonists with Vogel-type conflict test in rats. Eur J Pharmacol 264:107\u2013110","journal-title":"Eur J Pharmacol"},{"key":"2146_CR30","first-page":"1001","volume":"237","author":"MJ McLean","year":"1986","unstructured":"McLean MJ, Macdonald RL (1986) Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture. J Pharmacol Exp Ther 237:1001\u20131011","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 8","key":"2146_CR31","first-page":"30","volume":"64","author":"KJ Meador","year":"2003","unstructured":"Meador KJ (2003) Newer anticonvulsants: dosing strategies and cognition in treating patients with mood disorders and epilepsy. J Clin Psychiatry 64(Suppl 8):30\u201334","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 2","key":"2146_CR32","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1111\/j.1528-1157.1995.tb06002.x","volume":"36","author":"JA Messenheimer","year":"1995","unstructured":"Messenheimer JA (1995) Lamotrigine. Epilepsia 36(Suppl 2):S87\u2013S94","journal-title":"Epilepsia"},{"key":"2146_CR33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1528-1157.1986.tb03572.x","volume":"27","author":"AA Miller","year":"1986","unstructured":"Miller AA, Wheatley P, Sawyer DA, Baxter MG, Roth B (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. I. Anticonvulsant profile in mice and rats. Epilepsia 27:483\u2013489","journal-title":"Epilepsia"},{"key":"2146_CR34","first-page":"97","volume":"17","author":"M Nicolodi","year":"1997","unstructured":"Nicolodi M, Del Bianco PL, Sicuteri F (1997) Modulation of excitatory amino acids pathway: a possible therapeutic approach to chronic daily headache associated with analgesic drugs abuse. Int J Clin Pharmacol Res 17:97\u2013100","journal-title":"Int J Clin Pharmacol Res"},{"key":"2146_CR35","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","volume":"16","author":"E Perucca","year":"2002","unstructured":"Perucca E (2002) Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 16:695\u2013714","journal-title":"CNS Drugs"},{"key":"2146_CR36","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1073\/pnas.93.17.9270","volume":"93","author":"DS Ragsdale","year":"1996","unstructured":"Ragsdale DS, McPhee JC, Scheuer T, Catterall WA (1996) Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels. Proc Natl Acad Sci U S A 93:9270\u20139275","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2146_CR37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0006-8993(96)01447-3","volume":"752","author":"DS Reddy","year":"1997","unstructured":"Reddy DS, Kulkarni SK (1997) Differential anxiolytic effects of neurosteroids in the mirrored chamber behavior test in mice. Brain Res 752:61\u201371","journal-title":"Brain Res"},{"key":"2146_CR38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004850-200303000-00006","volume":"18","author":"FL Rocha","year":"2003","unstructured":"Rocha FL, Hara C (2003) Lamotrigine augmentation in unipolar depression. Int Clin Psychopharmacol 18:97\u201399","journal-title":"Int Clin Psychopharmacol"},{"key":"2146_CR39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0014-2999(98)00580-9","volume":"358","author":"E Southam","year":"1998","unstructured":"Southam E, Kirkby D, Higgins GA, Hagan RM (1998) Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats. Eur J Pharmacol 358:19\u201324","journal-title":"Eur J Pharmacol"},{"key":"2146_CR40","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4088\/JCP.v65n0301","volume":"65","author":"SM Stahl","year":"2004","unstructured":"Stahl SM (2004) Anticonvulsants as anxiolytics. Part 1. Tiagabine and other anticonvulsants with actions on GABA. J Clin Psychiatry 65:291\u2013292","journal-title":"J Clin Psychiatry"},{"key":"2146_CR41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s002130050137","volume":"128","author":"KJ Stanhope","year":"1996","unstructured":"Stanhope KJ, Dourish CT (1996) Effects of 5-HT1A receptor agonists, partial agonists and a silent antagonist on the performance of the conditioned emotional response test in the rat. Psychopharmacology (Berl) 128:293\u2013303","journal-title":"Psychopharmacology (Berl)"},{"key":"2146_CR42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0014-2999(96)00265-8","volume":"307","author":"A Stefani","year":"1996","unstructured":"Stefani A, Spadoni F, Siniscalchi A, Bernardi G (1996) Lamotrigine inhibits Ca2+ currents in cortical neurons: functional implications. Eur J Pharmacol 307:113\u2013116","journal-title":"Eur J Pharmacol"},{"key":"2146_CR43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/0024-3205(87)90229-3","volume":"41","author":"S Ueno","year":"1987","unstructured":"Ueno S, Matsuki N, Saito H (1987) Suncus murinus: a new experimental model in emesis research. Life Sci 41:513\u2013518","journal-title":"Life Sci"},{"key":"2146_CR44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF02805985","volume":"127","author":"MP Viveros","year":"1996","unstructured":"Viveros MP, Martin S, Ormazabal MJ, Alfaro MJ, Martin MI (1996) Effects of nimodipine and nifedipine upon behavior and regional brain monoamines in the rat. Psychopharmacology (Berl) 127:123\u2013132","journal-title":"Psychopharmacology (Berl)"},{"key":"2146_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00403989","volume":"21","author":"JR Vogel","year":"1971","unstructured":"Vogel JR, Beer B, Clody DE (1971) A simple and reliable conflict procedure for testing anti-anxiety agents. Psychopharmacologia 21:1\u20137","journal-title":"Psychopharmacologia"},{"key":"2146_CR46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0924-977X(96)00384-7","volume":"7","author":"J Wegerer Von","year":"1997","unstructured":"von Wegerer J, Hesslinger B, Berger M, Walden J (1997) A calcium antagonistic effect of the new antiepileptic drug lamotrigine. Eur Neuropsychopharmacol 7:77\u201381","journal-title":"Eur Neuropsychopharmacol"},{"key":"2146_CR47","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1212\/WNL.45.10.1907","volume":"45","author":"PC Waldmeier","year":"1995","unstructured":"Waldmeier PC, Baumann PA, Wicki P, Feldtrauer JJ, Stierlin C, Schmutz M (1995) Similar potency of carbamazepine, oxcarbazepine, and lamotrigine in inhibiting the release of glutamate and other neurotransmitters. Neurology 45:1907\u20131913","journal-title":"Neurology"},{"key":"2146_CR48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF00178716","volume":"354","author":"PC Waldmeier","year":"1996","unstructured":"Waldmeier PC, Martin P, Stocklin K, Portet C, Schmutz M (1996) Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn-Schmiedeberg\u2019s Arch Pharmacol 354:164\u2013172","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"2146_CR49","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0304-3959(98)00068-2","volume":"76","author":"J Webb","year":"1998","unstructured":"Webb J, Kamali F (1998) Analgesic effects of lamotrigine and phenytoin on cold-induced pain: a crossover placebo-controlled study in healthy volunteers. Pain 76:357\u2013363","journal-title":"Pain"},{"key":"2146_CR50","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s004240000448","volume":"441","author":"X Xie","year":"2001","unstructured":"Xie X, Dale TJ, John VH, Cater HL, Peakman TC, Clare JJ (2001) Electrophysiological and pharmacological properties of the human brain type IIA Na+ channel expressed in a stable mammalian cell line. Pflugers Arch 441:425\u2013433","journal-title":"Pflugers Arch"},{"key":"2146_CR51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1074\/jbc.M006992200","volume":"276","author":"V Yarov-Yarovoy","year":"2001","unstructured":"Yarov-Yarovoy V, Brown J, Sharp EM, Clare JJ, Scheuer T, Catterall WA (2001) Molecular determinants of voltage-dependent gating and binding of pore-blocking drugs in transmembrane segment IIIS6 of the Na(+) channel alpha subunit. J Biol Chem 276:20\u201327","journal-title":"J Biol Chem"},{"issue":"Suppl 10","key":"2146_CR52","first-page":"28","volume":"65","author":"LN Yatham","year":"2004","unstructured":"Yatham LN (2004) Newer anticonvulsants in the treatment of bipolar disorder. J Clin Psychiatry 65(Suppl 10):28\u201335","journal-title":"J Clin Psychiatry"},{"key":"2146_CR53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02253593","volume":"106","author":"H Zangrossi Jr","year":"1992","unstructured":"Zangrossi H Jr, Leite JR, Graeff FG (1992) Anxiolytic effect of carbamazepine in the elevated plus-maze: possible role of adenosine. Psychopharmacology (Berl) 106:85\u201389","journal-title":"Psychopharmacology (Berl)"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-2146-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-005-2146-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-005-2146-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:31:13Z","timestamp":1558629073000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-005-2146-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1,29]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["2146"],"URL":"https:\/\/doi.org\/10.1007\/s00213-005-2146-1","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,1,29]]}}}